Table I.
Cell line | Cetuximab sensitivity | Growth inhibition relative to control (%) | Culture medium |
---|---|---|---|
CACO2 | Resistant | 0 | EMEM + 1% NEAA + 10% FBS |
COLO320DM | Resistant | 0 | RPMI1640 + 10% FBS |
C10 | Partially resistant | 5.9 | IMDM + 10% FBS |
HT55 | Partially resistant | 21.3 | EMEM + 1% NEAA + 20% FBS |
SW48 | Sensitive | 69.1 | L15 + 10% FBS |
C99 | Sensitive | 96.8 | IMDM + 10% FBS |
CRC, colorectal cancer; NEAA, non-essential amino acids; FBS, fetal bovine serum.